A simple three-step approach for the assessment of bioequivalence is proposed. According to the decision rule of this approach, average bioequivalence is assessed first (Step 1). lf approved, then population bioequivalence will be assessed next (Step 2). Again, if approved, then individual bioequivalence can be assessed as thefinal stage (Step 3). For the evaluation of these bioequivalence criteria, parametric and nonparametric testing procedures are suggested on the original and logarithmic scale of measurement. A clear advantage of these testing procedures is that they can be set up using elementary test statistics and, therefore, they are readily accessible to the practitioners. An example is also presented to illustrate the method
For approval of generic drugs, the FDA requires that evidence of bioequivalence in average bioequiva...
Bioequivalence test procedure is used in clinical trials and environmental studies. In clinical tri...
The currently accepted statistical method for declaring bioequivalence (BE) is the Classical 90 % Co...
Statistical methods to assess bioequivalence of a test and a reference formulation for modified-rele...
It is shown that the standard two one-sided tests procedure for bioe-quivalence is a biased test. Be...
SUMMARY. A new approach has been developed for bioequivalence testing to avoid imprac-tical rejectio...
We will study here a general method for constructing equivalence tests for problems with onedimensio...
A generic drug product (test product) is bioequivalent to an innovator product (reference product) w...
Bioequivalence (BE) means the absence of a greater-than-allowable difference between the systemic bi...
[[abstract]]The approval of generic drugs requires the evidence of average bioequivalence (ABE) on b...
Bioequivalence of two medicinal, or veterinary, products is established by comparing the mean of bio...
Various aspects of bioequivalence are investigated in this paper. Some aspects dealing with bioequiv...
It is a one-sided hypothesis testing process for assessing bioequivalence. Bootstrap and modified la...
The statistical test of the hypothesis of no difference between the average bioavailabilities of two...
In this paper, we introduce a Bayesian analysis for bioequivalence data assuming multivariate pharma...
For approval of generic drugs, the FDA requires that evidence of bioequivalence in average bioequiva...
Bioequivalence test procedure is used in clinical trials and environmental studies. In clinical tri...
The currently accepted statistical method for declaring bioequivalence (BE) is the Classical 90 % Co...
Statistical methods to assess bioequivalence of a test and a reference formulation for modified-rele...
It is shown that the standard two one-sided tests procedure for bioe-quivalence is a biased test. Be...
SUMMARY. A new approach has been developed for bioequivalence testing to avoid imprac-tical rejectio...
We will study here a general method for constructing equivalence tests for problems with onedimensio...
A generic drug product (test product) is bioequivalent to an innovator product (reference product) w...
Bioequivalence (BE) means the absence of a greater-than-allowable difference between the systemic bi...
[[abstract]]The approval of generic drugs requires the evidence of average bioequivalence (ABE) on b...
Bioequivalence of two medicinal, or veterinary, products is established by comparing the mean of bio...
Various aspects of bioequivalence are investigated in this paper. Some aspects dealing with bioequiv...
It is a one-sided hypothesis testing process for assessing bioequivalence. Bootstrap and modified la...
The statistical test of the hypothesis of no difference between the average bioavailabilities of two...
In this paper, we introduce a Bayesian analysis for bioequivalence data assuming multivariate pharma...
For approval of generic drugs, the FDA requires that evidence of bioequivalence in average bioequiva...
Bioequivalence test procedure is used in clinical trials and environmental studies. In clinical tri...
The currently accepted statistical method for declaring bioequivalence (BE) is the Classical 90 % Co...